首页> 外文OA文献 >Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokines
【2h】

Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokines

机译:季节性变应性鼻炎中鼻腔S100A7(psoriasin)水平降低:Th2细胞因子介导的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: S100A7 is an antimicrobial peptide involved in several inflammatory diseases. The aim of the present study was to explore the expression and regulation of S100A7 in seasonal allergic rhinitis (SAR). less thanbrgreater than less thanbrgreater thanMethods: Nasal lavage (NAL) fluid was obtained from healthy controls before and after lipopolysaccharide (LPS) provocation, from SAR patients before and after allergen challenge, and from SAR patients having completed allergen-specific immunotherapy (ASIT). Nasal biopsies, nasal epithelial cells and blood were acquired from healthy donors. The airway epithelial cell line FaDu was used for in vitro experiments. Real-time RT-PCR and immunohistochemistry were used to determine S100A7 expression in nasal tissue and cells. Release of S100A7 in NAL and culture supernatants was measured by ELISA. The function of recombinant S100A7 was explored in epithelial cells, neutrophils and peripheral blood mononuclear cells (PBMC). less thanbrgreater than less thanbrgreater thanResults: Nasal administration of LPS induced S100A7 release in healthy non-allergic subjects. The level of S100A7 was lower in NAL from SAR patients than from healthy controls, and it was further reduced in the SAR group 6 h post allergen provocation. In contrast, ASIT patients displayed higher levels after completed treatment. S100A7 was expressed in the nasal epithelium and in glands, and it was secreted by cultured epithelial cells. Stimulation with IL-4 and histamine repressed the epithelial S100A7 release. Further, recombinant S100A7 induced activation of neutrophils and PBMC. less thanbrgreater than less thanbrgreater thanConclusions: The present study shows an epithelial expression and excretion of S100A7 in the nose after microbial stimulation. The levels are diminished in rhinitis patients and in the presence of an allergic cytokine milieu, suggesting that the antimicrobial defense is compromised in patients with SAR.
机译:背景:S100A7是一种涉及多种炎症性疾病的抗菌肽。本研究的目的是探讨S100A7在季节性变应性鼻炎(SAR)中的表达和调控。方法:从脂多糖(LPS)激发之前和之后的健康对照,从过敏原攻击前后的SAR患者以及完成过敏原特异性免疫疗法(ASIT)的SAR患者获得洗鼻液(NAL)。鼻活检,鼻上皮细胞和血液均来自健康供体。气道上皮细胞系FaDu用于体外实验。实时RT-PCR和免疫组织化学用于确定鼻腔组织和细胞中S100A7的表达。通过ELISA测量S100A7在NAL和培养上清液中的释放。在上皮细胞,嗜中性粒细胞和外周血单核细胞(PBMC)中探索了重组S100A7的功能。结果:鼻腔给药LPS诱导健康的非过敏性受试者中S100A7的释放。 SAR患者的NAL中S100A7的水平低于健康对照组,并且在过敏原激发后6小时的SAR组中S100A7的水平进一步降低。相比之下,完成治疗后ASIT患者显示出更高的水平。 S100A7在鼻上皮和腺体中表达,并由培养的上皮细胞分泌。 IL-4和组胺刺激抑制上皮S100A7释放。此外,重组S100A7诱导中性粒细胞和PBMC的活化。结论:本研究显示了微生物刺激后鼻中S100A7的上皮表达和排泄。鼻炎患者和存在变应性细胞因子环境时,该水平降低,这表明SAR患者的抗微生物防御能力受到损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号